Recombinant human erythropoietin in a triplet pregnancy - A case report
dc.creator | Lialios, G. | en |
dc.creator | Kallitsaris, A. | en |
dc.creator | Bourantas, K. L. | en |
dc.creator | Messinis, I. E. | en |
dc.date.accessioned | 2015-11-23T10:37:52Z | |
dc.date.available | 2015-11-23T10:37:52Z | |
dc.date.issued | 2005 | |
dc.identifier.issn | 0024-7758 | |
dc.identifier.uri | http://hdl.handle.net/11615/30314 | |
dc.description.abstract | BACKGROUND: Women carrying triplets are at greater risk for both anemia, due to the increased demands of the developing fetuses, and peripartum hemorrhage. Jehovah's witnesses are a unique obstetric population since women of this faith refuse blood transfusion. CASE: A Jehovah's Witness with a triplet pregnancy was successfully administered recombinant human erythropoietin (rHuEpo), 200 IU/kg 3 times per week subcutaneously, in order to correct her peripartum anemia. No side effects Were observed during rHuEpo therapy, and the patient delivered healthy triplets. CONCLUSION: rHuEpo can be safely administered, With a beneficial effect in pregnancy, and seems to be an effective option in preventing transfusions as demonstrated in this case in a Jehovah's Witness. | en |
dc.source | Journal of Reproductive Medicine | en |
dc.source.uri | <Go to ISI>://WOS:000233472900014 | |
dc.subject | recombinant erythropoietin | en |
dc.subject | triplets | en |
dc.subject | anemia | en |
dc.subject | JEHOVAH-WITNESSES | en |
dc.subject | Obstetrics & Gynecology | en |
dc.title | Recombinant human erythropoietin in a triplet pregnancy - A case report | en |
dc.type | journalArticle | en |
Αρχεία σε αυτό το τεκμήριο
Αρχεία | Μέγεθος | Τύπος | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |